|
|
|
|
| LEADER |
02450nam a2200817Ia 4500 |
| 001 |
10.5694-mja13.00214 |
| 008 |
220112s2014 CNT 000 0 und d |
| 020 |
|
|
|a 0025729X (ISSN)
|
| 245 |
1 |
0 |
|a Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia
|
| 260 |
|
0 |
|b Australasian Medical Publishing Co. Ltd
|c 2014
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.5694/mja13.00214
|
| 856 |
|
|
|z View in Scopus
|u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908406983&doi=10.5694%2fmja13.00214&partnerID=40&md5=5a1e722a1a0c59a164f93655394576fd
|
| 650 |
0 |
4 |
|a actinic keratosis
|
| 650 |
0 |
4 |
|a adult
|
| 650 |
0 |
4 |
|a amphotericin B lipid complex
|
| 650 |
0 |
4 |
|a antifungal agent
|
| 650 |
0 |
4 |
|a Antifungal Agents
|
| 650 |
0 |
4 |
|a Article
|
| 650 |
0 |
4 |
|a aspergillosis
|
| 650 |
0 |
4 |
|a Aspergillosis
|
| 650 |
0 |
4 |
|a Australia
|
| 650 |
0 |
4 |
|a bronchitis
|
| 650 |
0 |
4 |
|a Bronchitis
|
| 650 |
0 |
4 |
|a capecitabine
|
| 650 |
0 |
4 |
|a Carcinoma, Squamous Cell
|
| 650 |
0 |
4 |
|a case report
|
| 650 |
0 |
4 |
|a chemically induced
|
| 650 |
0 |
4 |
|a drug surveillance program
|
| 650 |
0 |
4 |
|a erythema
|
| 650 |
0 |
4 |
|a female
|
| 650 |
0 |
4 |
|a Female
|
| 650 |
0 |
4 |
|a graft recipient
|
| 650 |
0 |
4 |
|a human
|
| 650 |
0 |
4 |
|a human tissue
|
| 650 |
0 |
4 |
|a Humans
|
| 650 |
0 |
4 |
|a Keratosis, Actinic
|
| 650 |
0 |
4 |
|a lung transplantation
|
| 650 |
0 |
4 |
|a Lung Transplantation
|
| 650 |
0 |
4 |
|a microbiology
|
| 650 |
0 |
4 |
|a middle aged
|
| 650 |
0 |
4 |
|a Middle Aged
|
| 650 |
0 |
4 |
|a multiple cycle treatment
|
| 650 |
0 |
4 |
|a outcome assessment
|
| 650 |
0 |
4 |
|a parotid gland carcinoma
|
| 650 |
0 |
4 |
|a parotidectomy
|
| 650 |
0 |
4 |
|a phototoxicity
|
| 650 |
0 |
4 |
|a posaconazole
|
| 650 |
0 |
4 |
|a rash
|
| 650 |
0 |
4 |
|a skin carcinoma
|
| 650 |
0 |
4 |
|a skin defect
|
| 650 |
0 |
4 |
|a skin metastasis
|
| 650 |
0 |
4 |
|a Skin Neoplasms
|
| 650 |
0 |
4 |
|a skin tumor
|
| 650 |
0 |
4 |
|a squamous cell carcinoma
|
| 650 |
0 |
4 |
|a sun exposure
|
| 650 |
0 |
4 |
|a tracheitis
|
| 650 |
0 |
4 |
|a Tracheitis
|
| 650 |
0 |
4 |
|a tracheobronchitis
|
| 650 |
0 |
4 |
|a Transplant Recipients
|
| 650 |
0 |
4 |
|a tumor recurrence
|
| 650 |
0 |
4 |
|a voriconazole
|
| 650 |
0 |
4 |
|a Voriconazole
|
| 700 |
1 |
0 |
|a Kong, D.C.M.
|e author
|
| 700 |
1 |
0 |
|a Kotsimbos, T.
|e author
|
| 700 |
1 |
0 |
|a Levvey, B.
|e author
|
| 700 |
1 |
0 |
|a Morrissey, O.
|e author
|
| 700 |
1 |
0 |
|a Neoh, C.F.
|e author
|
| 700 |
1 |
0 |
|a Slavin, M.A.
|e author
|
| 700 |
1 |
0 |
|a Snell, G.I.
|e author
|
| 700 |
1 |
0 |
|a Stewart, K.
|e author
|
| 773 |
|
|
|t Medical Journal of Australia
|
